Medical treatment of ectopic pregnancy

Fertility and Sterility

Volumn 90, Issue 5 SUPPL., 2008, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

FOLINIC ACID; METHOTREXATE;

ARTICLE; COST BENEFIT ANALYSIS; DRUG EFFICACY; DRUG MECHANISM; DRUG TREATMENT FAILURE; ECHOGRAPHY; ECTOPIC PREGNANCY; ENDOMETRIUM BIOPSY; LAPAROSCOPY; MORBIDITY; MORTALITY; OVARY PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION; UNITED STATES;

ABORTIFACIENT AGENTS, NONSTEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEALTH PLANNING GUIDELINES; HUMANS; METHOTREXATE; PREGNANCY; PREGNANCY, ECTOPIC; PREVALENCE; PROGNOSIS; RISK FACTORS; TREATMENT FAILURE;

EID: 55449097790     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.08.049     Document Type: Article

References (57)

1. Berg C.J., Chang J., Callaghan W.M., and Whitehead S.J. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol 101 (2003) 289-296
2. Hajenius P.J., Engelsbel S., Mol B.W., Van der Veen F., Ankum W.M., Bossuyt P.M., et al. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet 350 (1997) 774-779
3. Centers for Disease Control and Prevention (CDC). Ectopic pregnancy-United States, 1990-1992. MMWR Morb Mortal Wkly Rep 44 (1995) 46-48
4. Zane S.B., Kieke Jr. B.A., Kendrick J.S., and Bruce C. Surveillance in a time of changing health care practices: estimating ectopic pregnancy incidence in the United States. Matern Child Health J 6 (2002) 227-236
5. Wong J.A., and Clark J.F. Correlation of symptoms with age and location of gestation in tubal pregnancy. J Natl Med Assoc 60 (1968) 221-223
6. Ankum W.M., Mol B.W., Van der Veen F., and Bossuyt P.M. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril 65 (1996) 1093-1099
7. Saraiya M., Berg C.J., Kendrick J.S., Strauss L.T., Atrash H.K., and Ahn Y.W. Cigarette smoking as a risk factor for ectopic pregnancy. Am J Obstet Gynecol 178 (1998) 493-498
8. Butts S., Sammel M., Hummel A., Chittams J., and Barnhart K. Risk factors and clinical features of recurrent ectopic pregnancy: a case control study. Fertil Steril 80 (2003) 1340-1344
9. Stovall T.G., Ling F.W., Carson S.A., and Buster J.E. Nonsurgical diagnosis and treatment of tubal pregnancy. Fertil Steril 54 (1990) 537-538
10. Barnhart K., Mennuti M.T., Benjamin I., Jacobson S., Goodman D., and Coutifaris C. Prompt diagnosis of ectopic pregnancy in an emergency department setting. Obstet Gynecol 84 (1994) 1010-1015
11. Gracia C.R., and Barnhart K.T. Diagnosing ectopic pregnancy: decision analysis comparing six strategies. Obstet Gynecol 97 (2001) 464-470
12. Fritz M.A., and Guo S.M. Doubling time of human chorionic gonadotropin (hCG) in early normal pregnancy: relationship to hCG concentration and gestational age. Fertil Steril 47 (1987) 584-589
13. Timor-Tritsch I.E., Yeh M.N., Peisner D.B., Lesser K.B., and Slavik T.A. The use of transvaginal ultrasonography in the diagnosis of ectopic pregnancy. Am J Obstet Gynecol 161 (1989) 157-161
14. Romero R., Kadar N., Copel J.A., Jeanty P., DeCherney A.H., and Hobbins J.C. The value of serial human chorionic gonadotropin testing as a diagnostic tool in ectopic pregnancy. Am J Obstet Gynecol 155 (1986) 392-394
15. Kadar N., and Romero R. Observations on the log human chorionic gonadotropin-time relationship in early pregnancy and its practical implications. Am J Obstet Gynecol 157 (1987) 73-78
16. Barnhart K.T., Sammel M.D., Rinaudo P.F., Zhou L., Hummel A.C., and Guo W. Symptomatic patients with an early viable intrauterine pregnancy: hCG curves redefined. Obstet Gynecol 104 (2004) 50-55
17. Chung K., Sammel M.D., Chalian R., Coutifaris C., Feedman M., and Barnhart K.T. Defining the rise of serum HCG in viable pregnancies achieved through use of IVF. Hum Reprod 213 (2006) 823-828
18. Kadar N., Freedman M., and Zacher M. Further observations on the doubling time of human chorionic gonadotropin in early asymptomatic pregnancies. Fertil Steril 54 (1990) 783-787
19. Barnhart K., Sammel M.D., Chung K., Zhou L., Hummel A.C., and Guo W. Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve. Obstet Gynecol 104 (2004) 975-981
20. Barnhart K.T., Katz I., Hummel A., and Gracia C.R. Presumed diagnosis of ectopic pregnancy. Obstet Gynecol 100 (2002) 505-510
21. Barnhart K.T., Gracia C.R., Reindl B., and Wheeler J.E. Usefulness of pipelle endometrial biopsy in the diagnosis of women at risk for ectopic pregnancy. Am J Obstet Gynecol 188 (2003) 906-909
22. Ries A., Singson P., Bidus M., and Barnes J.G. Use of the endometrial pipelle in the diagnosis of early abnormal gestations. Fertil Steril 74 (2000) 593-595
23. Ailawadi M., Lorch S.A., and Barnhart K.T. Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage. Fertil Steril 83 (2005) 376-382
24. Adam M.P., Manning M.A., Beck A.E., Kwan A., Enns G.M., Clericuzio C., et al. Methotrexate/misoprostol embryopathy: report of four cases resulting from failed medical abortion. Am J Med Genet A 123 (2003) 72-78
25. Berlin N.I., Rall D., Mead J.A., Freirreich E.J., Vanscott E., Hertz R., et al. Folic acid anatagonists: effects on the cell and the patient. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med 59 (1963) 931-956
26. Calabresi P., and Chabner B.A. Antineoplastic agents. In: Gilman A., Goodman L.S., and Goodman A. (Eds). The pharmacologic basis of therapeutics (1990), Macmillan Publishing, ed 8. New York 1275-1276
27. Rodi I.A., Sauer M.V., Gorrill M.J., Bustillo M., Gunning J.E., Marshall J.R., et al. The medical treatment of unruptured ectopic pregnancy with methotrexate and citrovorum rescue: preliminary experience. Fertil Steril 46 (1986) 811-813
28. Ory S.J., Villanueva A.L., Sand P.K., and Tamura R.K. Conservative treatment of ectopic pregnancy with methotrexate. Am J Obstet Gynecol 1546 (1986) 1299-1306
29. Stovall T.G., Ling F.W., and Buster J.E. Outpatient chemotherapy of unruptured ectopic pregnancy. Fertil Steril 51 (1989) 435-438
30. Pisarska M.D., Carson S.A., and Buster J.E. Ectopic pregnancy. Lancet 351 (1998) 1115-1120
31. Lipscomb G.H., Stovall T.G., and Ling F.W. Nonsurgical treatment of ectopic pregnancy. N Engl J Med 343 (2000) 1325-1329
32. Barnhart K., Coutifaris C., and Esposito M. The pharmacology of methotrexate. Expert Opin Pharmacother 2 (2001) 409-417
33. Stovall T.G., Ling F.W., and Gray L.A. Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol 77 (1991) 754-757
34. Lipscomb G.H., Bran D., McCord M.L., Portera J.C., and Ling F.W. Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexate. Am J Obstet Gynecol 178 (1998) 1354-1358
35. Barnhart K.T., Gosman G., Ashby R., and Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing "single dose and multidose" regimens. Obstet Gynecol 101 (2003) 778-784
36. Alleyassin A., Khademi A., Aghahosseini M., Safdarian L., Badenoosh B., and Hamed E.A. Comparison of success rates in the medical management of ectopic pregnancy with single-dose and multiple-dose administration of methotrexate: a prospective, randomized clinical trial. Fertil Steril 85 (2006) 1661-1666
37. Barnhart K.T., Sammel M.D., Hummel A., Jain J., Chakhtoura N., and Strauss J. A novel "two dose" regimen of methotrexate to treat ectopic pregnancy. [abstract]. Fertil Steril 84 Suppl (2005) S130
38. Tawfiq A., Agameya A.F., and Claman P. Predictors of treatment failure for ectopic pregnancy treated with single-dose methotrexate. Fertil Steril 74 (2000) 877-880
39. Potter M.B., Lepine L.A., and Jamieson D.J. Predictors of success with methotrexate treatment of tubal ectopic pregnancy at Grady Memorial Hospital. Am J Obstet Gynecol 188 (2003) 1192-1194
40. Elito Jr. J., Reichmann A.P., Uchiyama M.N., and Camano L. Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate. Int J Gynaecol Obstet 67 (1999) 75-79
41. Lipscomb G.H., McCord M.L., Stovall T.G., Huff G., Portera S.G., and Ling F.W. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 341 (1999) 1974-1978
42. Schoenfeld A., Mashiach R., Vardy M., and Ovadia J. Methotrexate pneumonitis in nonsurgical treatment of ectopic pregnancy. Obstet Gynecol 80 (1992) 520-521
43. Isaacs J.D., Mcgehee R.P., and Cowan B.D. Life-threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases. Obstet Gynecol 88 (1996) 694-696
44. Lipscomb G.H., Puckett K.J., Bran D., and Ling F.W. Management of separation pain after single-dose methotrexate therapy for ectopic pregnancy. Obstet Gynecol 93 (1999) 590-593
45. Dudley P., Heard M.J., Sangi-Haghpeykar H., Carson S.A., and Buster J.E. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate. Fertil Steril 82 (2004) 1374-1378
46. Atri M., Bret P.M., Tulandi T., and Senterman M.K. Ectopic pregnancy: evolution after treatment with transvaginal methotrexate. Radiology 185 (1992) 749-753
47. Graczykowski J.W., and Mishell Jr. D.R. Methotrexate prophylaxis for persistent ectopic pregnancy after conservative treatment by salpingostomy. Obstet Gynecol 89 (1997) 118-122
48. Gracia C.R., Brown H.A., and Barnhart K.T. Prophylactic methotrexate after linear salpingostomy: a decision analysis. Fertil Steril 76 (2001) 1191-1195
49. Jourdain O., Fontanges M., Schiano A., Rauch F., and Gonnet J.M. Management of other ectopic pregnancies (cornual, interstitial, angular, ovarian). J Gynecol Obstet Biol Reprod (Paris) 32 (2003) S93-S100
50. Chin H.Y., Chen F.P., Wang C.J., Shui L.T., Liu Y.H., and Soong Y.K. Heterotopic pregnancy after in vitro fertilization-embryo transfer. Int J Gynaecol Obstet 86 (2004) 411-416
51. Fernandez H., and Gervaise A. Ectopic pregnancies after infertility treatment: modern diagnosis and therapeutic strategy. Hum Reprod Update 10 (2004) 503-513
52. Barnhart K., Spandorfer S., and Coutifaris C. Medical treatment of interstitial pregnancy. A report of three unsuccessful cases. J Reprod Med 42 (1997) 521-524
53. Tulandi T., and Al-Jaroudi D. Interstitial pregnancy: results generated from the Society of Reproductive Surgeons Registry. Obstet Gynecol 103 (2004) 47-50
54. Cepni I., Ocal P., Erkan S., and Erzik B. Conservative treatment of cervical ectopic pregnancy with transvaginal ultrasound-guided aspiration and single-dose methotrexate. Fertil Steril 81 (2004) 1130-1132
55. Ushakov F.B., Elchalal U., Aceman P.J., and Schenker J.G. Cervical pregnancy: past and future. Obstet Gynecol Surv 52 (1997) 45-59
56. Morlock R.J., Lafata J.E., and Eisenstein D. Cost-effectiveness of single-dose methotrexate compared with laparoscopic treatment of ectopic pregnancy. Obstet Gynecol 95 (2000) 407-412
57. Sowter M.C., Farquhar C.M., and Gudex G. An economic evaluation of single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured ectopic pregnancy. BJOG 108 (2001) 204-212